VANCOUVER, British Columbia, Sept. 19, 2018 (GLOBE NEWSWIRE) -- ICC International Cannabis Corp. (formerly Kaneh Bosm BioTechnology Inc.) (CSE: KBB)(FWB: 8K51)(OTC: KNHBF)( the “Company”) is pleased to announce that further to its news release dated September 17, 2018, the Company has changed its name from “Kaneh Bosm BioTechnology Inc.” to “ICC International Cannabis Corp.”. The Company’s common shares will begin trading under the new name on September 20, 2018. There will be no change to the symbol and the Company’s common shares will continue to trade under the ticker “KBB”. The CUSIP number assigned to the Company’s common shares following the name change is 451079107 (ISIN: CA45107911078). No action is required to be taken by shareholders with respect to the name change. Outstanding share certificates are not affected by the name change and do not need to be exchanged.
On behalf of the Board of Directors of ICC International Cannabis Corp.
“Michael Martinz”
Michael Martinz
President, Director
mmartinz@kanehbosmbiotech.com
Tel: 604.687.2308
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.